Cytokinetics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2001
Net Income	-526.24	-388.96	-215.31	-127.29	-121.69	-106.29	-127.79	16.45	-37.5	-14.65	Upgrade
Depreciation & Amortization	11.89	5.81	2.28	1.83	1.29	1.24	1.92	0.74	0.59	0.49	Upgrade
Share-Based Compensation	72.07	47.85	26.83	17.62	10.76	9.76	9.03	7.15	4.57	3.33	Upgrade
Other Operating Activities	27.95	35.77	43.68	116.78	18.73	-5.93	15.08	12.64	37.23	-34.02	Upgrade
Operating Cash Flow	-414.33	-299.52	-142.52	8.94	-90.91	-101.22	-101.76	36.98	4.88	-44.84	Upgrade
Operating Cash Flow Growth	-	-	-	-	-	-	-	657.36%	-	-	Upgrade
Capital Expenditures	-1.42	-11.34	-48.87	-11.05	-2.62	-0.88	-2.88	-1.56	-0.56	-1.1	Upgrade
Change in Investments	240.67	-250.8	-98.91	-185.46	-72.09	6.01	-62.95	-50.51	16.62	-2.95	Upgrade
Investing Cash Flow	239.25	-262.13	-147.78	-196.52	-74.71	5.13	-65.83	-52.08	16.06	-4.05	Upgrade
Share Issuance / Repurchase	182.69	17.54	324.43	234.23	37.61	3.23	134.04	1.9	9.03	48.95	Upgrade
Debt Issued / Paid	-0.86	332.25	0	0	122.18	9.9	1.26	15	14.89	0	Upgrade
Other Financing Activities	39.48	166.37	-4.45	-0.1	-	-	90.62	-	-	-	Upgrade
Financing Cash Flow	221.32	516.17	319.98	234.12	159.79	13.13	225.92	16.89	23.92	48.95	Upgrade
Exchange Rate Effect	-0.02	0	0	0	0	0	0	0	0	0	Upgrade
Net Cash Flow	46.22	-45.48	29.68	46.55	-5.82	-82.95	58.33	1.8	44.86	0.06	Upgrade
Free Cash Flow	-415.75	-310.85	-191.39	-2.11	-93.53	-102.09	-104.64	35.42	4.32	-45.95	Upgrade
Free Cash Flow Growth	-	-	-	-	-	-	-	719.50%	-	-	Upgrade
Free Cash Flow Margin	-5521.24%	-328.64%	-271.76%	-3.78%	-348.09%	-324.08%	-782.73%	33.29%	15.08%	-97.88%	Upgrade
Free Cash Flow Per Share	-4.31	-3.46	-2.49	-0.03	-1.62	-1.88	-2.12	0.89	0.11	-1.29	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).